The authors concluded that mitral valve repair for ischaemic mitral regurgitation was associated with better short-and long-term survival than mitral valve replacement. The conclusions were limited because of the use of retrospective studies. Further randomised controlled trials were needed. The small number, small sample sizes and poor quality of the included studies mean that the authors' caution is warranted.
Study selection
Studies that compared mitral valve repair directly with mitral valve replacement in patients with chronic IMR and reported survival curves or hazard ratios were eligible for inclusion. Studies needed to use annuloplasty or suture/Teflon strip/pericardial strip annuloplasty in more than 10% of patients in the repair group. Studies of patients with nonischaemic dilated cardiomyopathy, preoperatively haemodynamically unstable patients and studies with ischaemic aetiology of the mitral regurgitation in a subset of patients only and with outcomes not reported for the ischaemic subset were excluded. Studies of concomitant surgical ventricular restoration or beating heart procedures were excluded.
Most patients in the included studies had concomitant coronary artery bypass. Most received a mechanical prosthesis. Mean ejection fractions ranged from 29% to 45% in the repair group and 36% to 44% in the replacement group. In some studies there were significant differences between groups in incidence of comorbidities or mean ejection fractions.
